Search / Trial NCT06227403

Leadership, Engagement, and Youth Activism Program With Mindfulness (LEAP)

Launched by BOSTON UNIVERSITY CHARLES RIVER CAMPUS · Jan 17, 2024

Trial Information

Current as of October 03, 2024

Recruiting

Keywords

Mindfulness Civic Engagement Youth Leadership Youth Wellbeing

Description

The LEAP-M study will determine whether a 14-session program designed to provide leadership and mindfulness skills to youth of color is an effective and feasible intervention. The curriculum consists of 14 two-hour sessions delivered after school. The comparison group will take part in EnvisionIT, a college and career readiness program designed for students in grades 6 through 12. EnvisionIT aims to prepare students with essential transition skills, digital literacy, and college and career readiness. The comparison group will also have 14 two-hour group sessions. Both LEAP-M and EnvisionIT ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Adolescents ages 14-18 in grades 9-12 enrolled in collaborating sites, either at Metropolitan Council for Educational Opportunity (METCO) in Boston, MA, or University of Illinois/Chicago Public School.
  • Exclusion Criteria:
  • * Adolescents who are not available to commit to the intervention schedule.
  • * Adolescents who are not in grades 9-12.
  • * Parents/guardians with preferred language other than English or Spanish.

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Chicago, Illinois, United States

Boston, Massachusetts, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0